(Reuters) - Merck & Co Inc said on Monday long-term data from its cancer immunotherapy Keytruda showed promise in treating advanced melanoma... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/EndTtumFDx0/mercks-keytruda-shows-promise-in-treating-advanced-melanoma-idINKCN1J01JO
(Reuters) - Merck & Co said on Wednesday its drug Keytruda helped patients with a certain type of lung cancer live longer and prevented the disease... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/F8YvZXuZnMU/mercks-cancer-drug-keytruda-notches-another-trial-success-idINKCN1IO1L4
Posted by Equitymaster After opening the day on a positive note, stock markets in India have continued their momentum. Sectoral indices are trading... ...http://www.equitymaster.com/tm/tm.asp?date=4/30/2018&title=Indian-Indices-Continue-Momentum-Sensex-Up-Over-200-Points
& Co reported a better-than-expected first-quarter profit on Tuesday and raised its adjusted earnings forecast for the year, helped by a more than... ...http://www.business-standard.com/article/reuters/keytruda-powers-merck-to-first-quarter-beat-118050100606_1.html
(Reuters) - A U.S. appeals court on Wednesday affirmed a ruling that pharmaceutical company Merck & Co dishonestly obtained patent rights and was... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/KzZRykAFss4/u-s-court-upholds-dismissal-of-200-million-merck-verdict-against-gilead-idINKBN1HW24U
Welcome Greetings! To our esteemed...